Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 08 04:00PM ET
136.76
Dollar change
+2.18
Percentage change
1.62
%
IndexRUT P/E42.32 EPS (ttm)3.23 Insider Own2.59% Shs Outstand33.33M Perf Week8.15%
Market Cap4.66B Forward P/E22.54 EPS next Y6.07 Insider Trans-4.32% Shs Float32.67M Perf Month6.65%
Income113.55M PEG1.97 EPS next Q1.46 Inst Own112.15% Short Float8.07% Perf Quarter18.50%
Sales1.70B P/S2.75 EPS this Y14.25% Inst Trans5.61% Short Ratio10.03 Perf Half Y20.00%
Book/sh48.33 P/B2.83 EPS next Y13.71% ROA3.81% Short Interest2.64M Perf Year59.25%
Cash/sh1.04 P/C131.05 EPS next 5Y21.53% ROE7.42% 52W Range83.69 - 136.07 Perf YTD38.03%
Dividend Est.- P/FCF62.79 EPS past 5Y- ROI4.09% 52W High0.51% Beta1.10
Dividend TTM- Quick Ratio2.09 Sales past 5Y6.27% Gross Margin25.44% 52W Low63.41% ATR (14)3.65
Dividend Ex-Date- Current Ratio3.28 EPS Y/Y TTM38.45% Oper. Margin13.07% RSI (14)64.86 Volatility2.51% 2.71%
Employees10500 Debt/Eq0.72 Sales Y/Y TTM8.80% Profit Margin6.70% Recom1.40 Target Price140.88
Option/ShortYes / Yes LT Debt/Eq0.71 EPS Q/Q22.70% Payout0.00% Rel Volume0.75 Prev Close134.58
Sales Surprise-2.08% EPS Surprise5.03% Sales Q/Q5.95% EarningsOct 24 BMO Avg Volume262.81K Price136.76
SMA205.65% SMA506.49% SMA20015.44% Trades Volume196,445 Change1.62%
Date Action Analyst Rating Change Price Target Change
Jul-16-24Initiated Oppenheimer Outperform $135
May-15-24Initiated Truist Buy $137
Apr-15-24Upgrade BofA Securities Neutral → Buy $105 → $135
Mar-14-24Initiated CL King Buy $137
Feb-06-24Resumed KeyBanc Capital Markets Overweight $125
May-26-23Initiated Wells Fargo Equal Weight $87
May-11-23Initiated Citigroup Neutral $88
Mar-30-23Initiated BofA Securities Neutral $86
Feb-24-23Initiated Piper Sandler Overweight $85
Jun-09-21Upgrade Argus Hold → Buy $100
Nov-01-24 07:00AM
07:00AM
Oct-29-24 09:45AM
Oct-25-24 08:29AM
05:57AM
03:11AM Loading…
03:11AM
Oct-24-24 08:15AM
08:00AM
08:00AM
Oct-23-24 09:05AM
Oct-09-24 12:21PM
Oct-02-24 04:05PM
06:00AM
Sep-30-24 08:00AM
08:00AM
08:00AM Loading…
Sep-26-24 08:00AM
Sep-23-24 08:00AM
Sep-20-24 09:40AM
Sep-18-24 09:45AM
Sep-10-24 09:50AM
Sep-04-24 09:40AM
Sep-02-24 09:45AM
Aug-23-24 08:18AM
Aug-22-24 08:00AM
Aug-16-24 01:23PM
Aug-01-24 07:02PM
09:50AM
08:00AM
Jul-31-24 09:45AM
Jul-29-24 09:40AM
12:54PM Loading…
Jul-26-24 12:54PM
Jul-25-24 08:13AM
08:00AM
07:00AM
Jul-01-24 04:05PM
Jun-28-24 09:40AM
Jun-27-24 04:00PM
Jun-12-24 11:51AM
Jun-06-24 07:01PM
04:00PM
May-24-24 12:38PM
May-15-24 06:14AM
May-14-24 04:22PM
May-13-24 11:22AM
May-09-24 04:48PM
May-07-24 08:00AM
May-01-24 08:00AM
Apr-30-24 09:06AM
Apr-26-24 01:07PM
Apr-25-24 11:42PM
12:53PM
10:00AM
09:32AM
09:15AM
08:00AM
Apr-18-24 10:01AM
Apr-16-24 09:15AM
Apr-13-24 12:18PM
Apr-10-24 01:31PM
Apr-09-24 11:47AM
Mar-28-24 08:00AM
Mar-25-24 09:45AM
Mar-14-24 09:40AM
Mar-12-24 08:00AM
Mar-08-24 08:21AM
Feb-27-24 09:40AM
Feb-16-24 10:53AM
09:19AM
Feb-15-24 11:27PM
08:42AM
08:12AM
08:00AM
Feb-12-24 09:15AM
Feb-07-24 09:40AM
Feb-01-24 08:00AM
Jan-23-24 09:50AM
Jan-22-24 09:40AM
Jan-17-24 09:15AM
Jan-16-24 08:00AM
06:18AM
Jan-15-24 10:33AM
Jan-11-24 09:21AM
Jan-10-24 04:15PM
Jan-03-24 09:40AM
08:00AM
Dec-29-23 09:15AM
Dec-21-23 07:42AM
Dec-15-23 09:40AM
Dec-13-23 10:57AM
09:15AM
Nov-24-23 09:40AM
Nov-20-23 10:41AM
Nov-16-23 08:00AM
Nov-08-23 08:00AM
Nov-03-23 12:27PM
12:22PM
09:40AM
09:35AM
09:34AM
09:34AM
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. It operates through the Medical and Non-Medical segments. The Medical segment includes the cardio and vascular, cardiac and neuromodulation, surgical, orthopedics, and portable medical product lines. The Non-Medical segment comprises customized battery power and management systems, charging and docking stations, and power supplies. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hobby Jean M.DirectorJul 31 '24Option Exercise42.2911,385481,50818,265Aug 01 04:55 PM
Hobby Jean M.DirectorJul 31 '24Sale119.6611,9601,431,1322,280Aug 01 04:55 PM
MAXWELL MARTIN CDirectorJul 31 '24Sale118.884,700558,72420,656Aug 01 04:42 PM
Harris John AEVP, Global Ops and ManufacturJul 30 '24Sale123.803,400420,9201,522Aug 01 04:38 PM
Hobby Jean M.DirectorJul 31 '24Proposed Sale119.6611,9601,431,132Jul 31 01:16 PM
MAXWELL MARTIN CDirectorJul 31 '24Proposed Sale119.154,700560,000Jul 31 12:50 PM
Harris John AOfficerJul 30 '24Proposed Sale123.803,400420,920Jul 30 02:34 PM
Harris John AEVP, Global Ops and ManufacturJun 04 '24Sale120.441,521183,1824,922Jun 06 04:05 PM
Hinrichs James F.DirectorMay 24 '24Option Exercise44.609,603428,29417,027May 28 03:20 PM
Hinrichs James F.DirectorMay 24 '24Sale122.449,6031,175,7727,424May 28 03:20 PM
Khales PaymanPresident, C&VMay 10 '24Sale113.848,712991,73910,431May 14 04:08 PM
Harris John AEVP, Global Ops and ManufacturMay 07 '24Sale113.0031235,2561,157May 09 04:13 PM
Senn AndrewSVP, Strategy and Business DevMay 07 '24Sale113.145,000565,7084,658May 09 04:12 PM
Thomas Tommy PVP, Corporate ControllerApr 30 '24Sale114.001,500171,0002,813May 02 04:08 PM
BAILEY PAMELA GDirectorJan 02 '24Option Exercise40.861,72270,36151,266Jan 03 04:26 PM
Dziedzic Joseph WPresident & CEOJan 02 '24Option Exercise40.861,72270,361159,535Jan 03 04:24 PM
Last Close
Nov 08 04:00PM ET
19.41
Dollar change
+1.19
Percentage change
6.53
%
OFIX Orthofix Medical Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-3.14 Insider Own3.49% Shs Outstand37.16M Perf Week14.45%
Market Cap790.19M Forward P/E- EPS next Y-0.91 Insider Trans0.00% Shs Float36.88M Perf Month29.40%
Income-119.03M PEG- EPS next Q-0.27 Inst Own94.54% Short Float6.91% Perf Quarter21.01%
Sales784.25M P/S1.01 EPS this Y31.88% Inst Trans-0.54% Short Ratio11.00 Perf Half Y32.58%
Book/sh13.76 P/B1.41 EPS next Y67.67% ROA-13.42% Short Interest2.55M Perf Year63.66%
Cash/sh0.80 P/C24.28 EPS next 5Y9.40% ROE-20.86% 52W Range9.57 - 19.47 Perf YTD43.99%
Dividend Est.- P/FCF- EPS past 5Y- ROI-17.73% 52W High-0.31% Beta1.06
Dividend TTM- Quick Ratio1.11 Sales past 5Y13.08% Gross Margin65.83% 52W Low102.72% ATR (14)0.72
Dividend Ex-Date- Current Ratio2.39 EPS Y/Y TTM19.53% Oper. Margin-10.91% RSI (14)79.11 Volatility5.58% 3.83%
Employees1634 Debt/Eq0.30 Sales Y/Y TTM17.32% Profit Margin-15.18% Recom1.80 Target Price24.40
Option/ShortYes / Yes LT Debt/Eq0.28 EPS Q/Q8.15% Payout- Rel Volume2.91 Prev Close18.22
Sales Surprise0.04% EPS Surprise-105.80% Sales Q/Q6.85% EarningsNov 07 BMO Avg Volume231.49K Price19.41
SMA2016.79% SMA5019.54% SMA20030.72% Trades Volume673,214 Change6.53%
Date Action Analyst Rating Change Price Target Change
Nov-08-24Upgrade Stifel Hold → Buy $18 → $24
May-08-24Upgrade ROTH MKM Neutral → Buy $15 → $20
Oct-20-23Initiated ROTH MKM Neutral $12
Sep-12-23Downgrade Stifel Buy → Hold
Sep-12-23Downgrade BTIG Research Buy → Neutral
Jul-19-23Resumed BTIG Research Buy $27
Mar-04-22Upgrade Stifel Hold → Buy $41 → $45
Oct-20-20Initiated Stifel Hold $39
Oct-29-19Downgrade Cantor Fitzgerald Overweight → Neutral $71 → $48
Jun-01-18Initiated Cantor Fitzgerald Overweight
Nov-08-24 07:32AM
02:14AM
Nov-07-24 08:25AM
07:23AM
07:05AM
07:05AM Loading…
07:05AM
Nov-06-24 07:30AM
Oct-21-24 07:00AM
Oct-10-24 07:00AM
Oct-09-24 12:34PM
Sep-27-24 05:45AM
Sep-23-24 07:00AM
Sep-13-24 05:45AM
Aug-30-24 10:22AM
Aug-15-24 05:52PM
06:09AM Loading…
Aug-07-24 06:09AM
Aug-06-24 08:15AM
07:17AM
07:03AM
Jul-17-24 07:00AM
Jul-16-24 07:00AM
Jul-10-24 12:13PM
06:32AM
Jul-09-24 07:00AM
07:00AM
Jun-24-24 07:00AM
03:11AM
Jun-18-24 07:00AM
Jun-11-24 07:00AM
May-23-24 07:00AM
07:15AM Loading…
May-16-24 07:15AM
May-13-24 11:18AM
May-09-24 07:00AM
May-08-24 01:03PM
07:43AM
03:16AM
May-07-24 10:38PM
01:53PM
09:34AM
08:21AM
08:00AM
Apr-26-24 06:37AM
Apr-23-24 07:00AM
Apr-16-24 07:00AM
Mar-18-24 07:00AM
Mar-12-24 11:01AM
Mar-07-24 01:40PM
09:53AM
Mar-06-24 08:21AM
Mar-05-24 10:52PM
04:42PM
04:03PM
Feb-29-24 07:00AM
Feb-21-24 07:00AM
Jan-18-24 07:00AM
Jan-16-24 07:00AM
Jan-09-24 08:00AM
Jan-08-24 07:00AM
Dec-27-23 08:45AM
Dec-21-23 07:00AM
Dec-12-23 07:00AM
Dec-11-23 09:55AM
Dec-01-23 06:16PM
Nov-29-23 12:21PM
07:00AM
Nov-28-23 11:30AM
07:00AM
Nov-27-23 10:48AM
Nov-24-23 12:28PM
Nov-23-23 09:55AM
Nov-21-23 06:30PM
Nov-13-23 09:00AM
Nov-09-23 01:43PM
Nov-08-23 05:36PM
04:07PM
09:00AM
Nov-07-23 03:59PM
Nov-06-23 07:00AM
Nov-02-23 10:00AM
Nov-01-23 10:01AM
Oct-31-23 01:48PM
Oct-29-23 09:00PM
Oct-23-23 09:00PM
03:54PM
Oct-18-23 09:00PM
07:00AM
Oct-17-23 08:33AM
Oct-13-23 09:00PM
08:40PM
08:23AM
Oct-12-23 09:10AM
07:00AM
Oct-09-23 05:25PM
01:48PM
Oct-08-23 09:00PM
Oct-06-23 09:13AM
Oct-02-23 09:00PM
Sep-27-23 09:00PM
Sep-21-23 09:22AM
Sep-20-23 07:00AM
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kenny Kevin J.President of Global SpineJan 08 '24Option Exercise0.005,9590147,321Jan 10 04:55 PM
Last Close
Nov 08 04:00PM ET
0.7670
Dollar change
-0.0091
Percentage change
-1.17
%
OM Outset Medical Inc daily Stock Chart
Index- P/E- EPS (ttm)-2.77 Insider Own8.24% Shs Outstand50.32M Perf Week25.74%
Market Cap39.83M Forward P/E- EPS next Y-1.42 Insider Trans-1.94% Shs Float48.21M Perf Month25.84%
Income-140.94M PEG- EPS next Q-0.42 Inst Own91.22% Short Float7.20% Perf Quarter-12.85%
Sales114.73M P/S0.35 EPS this Y28.15% Inst Trans-21.30% Short Ratio1.79 Perf Half Y-75.02%
Book/sh0.91 P/B0.84 EPS next Y27.06% ROA-46.94% Short Interest3.47M Perf Year-79.21%
Cash/sh3.38 P/C0.23 EPS next 5Y23.80% ROE-141.02% 52W Range0.44 - 6.37 Perf YTD-85.82%
Dividend Est.- P/FCF- EPS past 5Y-15.08% ROI-56.79% 52W High-87.96% Beta2.05
Dividend TTM- Quick Ratio5.04 Sales past 5Y202.67% Gross Margin30.97% 52W Low76.32% ATR (14)0.08
Dividend Ex-Date- Current Ratio6.49 EPS Y/Y TTM22.69% Oper. Margin-112.32% RSI (14)66.73 Volatility16.76% 9.24%
Employees480 Debt/Eq4.23 Sales Y/Y TTM-13.00% Profit Margin-122.84% Recom2.25 Target Price2.89
Option/ShortYes / Yes LT Debt/Eq4.19 EPS Q/Q40.20% Payout- Rel Volume0.79 Prev Close0.78
Sales Surprise6.81% EPS Surprise11.36% Sales Q/Q-5.59% EarningsNov 06 AMC Avg Volume1.94M Price0.77
SMA2027.77% SMA5033.02% SMA200-67.99% Trades Volume1,529,728 Change-1.17%
Date Action Analyst Rating Change Price Target Change
Aug-08-24Downgrade RBC Capital Mkts Outperform → Sector Perform $6 → $3
Jun-21-24Upgrade RBC Capital Mkts Sector Perform → Outperform $5 → $6
Apr-08-24Initiated BTIG Research Buy $6
Apr-05-24Upgrade CL King Neutral → Buy $6
Jan-12-24Downgrade RBC Capital Mkts Outperform → Sector Perform $14 → $6
Oct-13-23Downgrade BofA Securities Buy → Underperform $32 → $3
Aug-17-23Initiated CL King Neutral
Nov-11-22Initiated RBC Capital Mkts Outperform $23
Jul-14-22Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $20
Mar-02-22Resumed BofA Securities Buy $50
Nov-07-24 04:00PM
Nov-06-24 05:25PM
04:02PM
Nov-05-24 08:09AM
Oct-23-24 04:05PM
09:00AM Loading…
09:00AM
Oct-18-24 04:25AM
Oct-16-24 06:56PM
Oct-14-24 01:27PM
Oct-11-24 06:45AM
Sep-27-24 08:26AM
Sep-23-24 03:57PM
Sep-20-24 09:13AM
Sep-17-24 05:45AM
Sep-13-24 05:45AM
01:23AM Loading…
Sep-12-24 01:23AM
01:14AM
01:08AM
Sep-11-24 03:44PM
Sep-09-24 04:10PM
Sep-06-24 01:47PM
Sep-04-24 03:23PM
Sep-03-24 11:57AM
Aug-31-24 05:52PM
Aug-26-24 09:00PM
Aug-07-24 06:35PM
04:03PM
Jul-31-24 10:01AM
Jul-24-24 09:00AM
Jul-01-24 06:00AM
12:00PM Loading…
Jun-10-24 12:00PM
Jun-03-24 04:05PM
May-13-24 06:59AM
May-10-24 03:48PM
May-09-24 03:44PM
09:42AM
03:57AM
May-08-24 08:58PM
05:45PM
04:02PM
May-06-24 08:48AM
08:00AM
May-03-24 09:43AM
May-01-24 04:30PM
Apr-19-24 08:30AM
Apr-18-24 01:36PM
Apr-17-24 08:30AM
Apr-15-24 08:30AM
Mar-13-24 04:02PM
Mar-05-24 03:34PM
Feb-26-24 09:00AM
Feb-22-24 10:51AM
07:10AM
Feb-21-24 04:49PM
04:05PM
Feb-20-24 04:25PM
Feb-05-24 10:00AM
08:30AM
Jan-08-24 08:30AM
Jan-03-24 08:30AM
Nov-29-23 04:05PM
Nov-25-23 11:43AM
Nov-23-23 06:30AM
Nov-16-23 02:46PM
Nov-09-23 04:05PM
Nov-07-23 04:31PM
04:05PM
Nov-02-23 10:00AM
09:35AM
Nov-01-23 09:00AM
Oct-31-23 02:00PM
10:01AM
Oct-30-23 04:05PM
Oct-27-23 11:42AM
Oct-19-23 12:31PM
Oct-17-23 05:36PM
09:35AM
Oct-16-23 08:14AM
Oct-13-23 07:21PM
09:50AM
Oct-12-23 04:05PM
Aug-29-23 04:05PM
Aug-14-23 09:24PM
Aug-02-23 05:55PM
04:05PM
Jul-13-23 08:30AM
Jul-10-23 01:09PM
10:48AM
Jun-15-23 06:56AM
Jun-06-23 04:05PM
May-30-23 07:30AM
May-05-23 06:14AM
May-04-23 09:13AM
May-03-23 06:35PM
04:05PM
Apr-30-23 05:50AM
Apr-25-23 08:30AM
Apr-23-23 07:03AM
Apr-12-23 09:05AM
08:30AM
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Trigg LeslieChair and CEOAug 15 '24Sale0.845,3084,459910,496Aug 15 08:02 PM
Nash MarcSVP Operations and R&DAug 15 '24Sale0.841,2931,086239,397Aug 15 08:01 PM
Brottem John L.General CounselAug 15 '24Sale0.843,0112,529230,295Aug 15 07:59 PM
Ahmed NabeelChief Financial OfficerAug 15 '24Sale0.843,9713,336314,988Aug 15 07:57 PM
Trigg LeslieOfficerAug 15 '24Proposed Sale0.845,3084,459Aug 15 06:49 PM
Nash MarcOfficerAug 15 '24Proposed Sale0.841,2931,086Aug 15 06:49 PM
Brottem John L.OfficerAug 15 '24Proposed Sale0.843,0112,529Aug 15 06:47 PM
Ahmed NabeelOfficerAug 15 '24Proposed Sale0.843,9713,336Aug 15 06:46 PM
Nash MarcSVP Operations and R&DJul 24 '24Sale4.027232,906240,690Jul 24 07:08 PM
Brottem John L.General CounselJun 12 '24Sale4.7810,56950,520233,306Jun 14 04:17 PM
GROSSMAN D KEITHDirectorJun 03 '24Option Exercise1.1169,30376,92685,922Jun 03 06:57 PM
GROSSMAN D KEITHDirectorJun 03 '24Sale3.7838,117144,23447,805Jun 03 06:57 PM
Ahmed NabeelChief Financial OfficerMay 16 '24Sale3.533,91813,831318,959May 17 05:40 PM
Nash MarcSVP Operations and R&DMay 16 '24Sale3.531,0973,872241,413May 17 05:38 PM
Brottem John L.General CounselMay 16 '24Sale3.532,97210,491243,875May 17 05:36 PM
Trigg LeslieChair and CEOMay 16 '24Sale3.535,23718,487915,804May 17 05:25 PM
Racine Jean-OlivierChief Technology OfficerMay 10 '24Sale3.278,30627,161265,325May 10 06:19 PM
Nash MarcSVP Operations and R&DMar 15 '24Sale2.132,3915,093242,510Mar 15 06:40 PM
Ahmed NabeelChief Financial OfficerMar 01 '24Sale3.151,5844,990322,877Mar 04 04:34 PM
Williamson Steven S.Chief Commercial OfficerFeb 15 '24Sale3.572,5008,925320,347Feb 16 05:31 PM
Trigg LeslieChair and CEOFeb 15 '24Sale3.575,32018,992833,091Feb 16 05:29 PM
Racine Jean-OlivierChief Technology OfficerFeb 15 '24Sale3.571,8666,662271,830Feb 16 05:28 PM
Nash MarcSVP Operations and R&DFeb 15 '24Sale3.576172,203243,100Feb 16 05:27 PM
Brottem John L.General CounselFeb 15 '24Sale3.573,34111,927245,046Feb 16 05:26 PM
Ahmed NabeelChief Financial OfficerFeb 15 '24Sale3.574,40315,719312,594Feb 16 05:24 PM
Williamson Steven S.Chief Commercial OfficerJan 16 '24Sale4.299964,273322,847Jan 17 08:04 PM
Trigg LeslieChair and CEOJan 16 '24Sale4.298,12634,861838,411Jan 17 08:03 PM
Racine Jean-OlivierChief Technology OfficerJan 16 '24Sale4.297233,102273,696Jan 17 08:03 PM
Porter Stacey L.Chief People OfficerJan 16 '24Sale4.297683,29561,448Jan 17 08:02 PM
Nash MarcSVP Operations and R&DJan 16 '24Sale429.00678290,862243,717Jan 17 08:01 PM
Brottem John L.General CounselJan 16 '24Sale4.291,4806,349248,387Jan 17 08:00 PM
Ahmed NabeelChief Financial OfficerJan 16 '24Sale4.291,7267,405316,997Jan 17 07:59 PM
Williamson Steven S.Chief Commercial OfficerJan 08 '24Sale5.497,05538,732105,939Jan 08 08:35 PM
Trigg LeslieChair and CEOJan 08 '24Sale5.4914,18877,892389,099Jan 08 08:34 PM
Racine Jean-OlivierChief Technology OfficerJan 08 '24Sale5.493,90521,43873,781Jan 08 08:33 PM
Porter Stacey L.Chief People OfficerJan 08 '24Sale5.494,76626,16558,630Jan 08 08:31 PM
Brottem John L.General CounselJan 08 '24Sale5.497,34440,31948,807Jan 08 08:30 PM
Ahmed NabeelChief Financial OfficerJan 08 '24Sale5.4910,70958,79276,819Jan 08 08:29 PM
Williamson Steven S.Chief Commercial OfficerNov 16 '23Sale4.763,58417,060112,994Nov 17 04:22 PM
Trigg LeslieChair and CEONov 16 '23Sale4.763,17515,113403,287Nov 17 04:19 PM
Racine Jean-OlivierChief Technology OfficerNov 16 '23Sale4.767903,76077,686Nov 17 04:18 PM
Porter Stacey L.Chief People OfficerNov 16 '23Sale4.766713,19463,396Nov 17 04:17 PM
Nash MarcSVP Operations and R&DNov 16 '23Sale4.765622,67544,757Nov 17 04:15 PM
Brottem John L.General CounselNov 16 '23Sale4.761,4316,81256,151Nov 17 04:15 PM
Ahmed NabeelChief Financial OfficerNov 16 '23Sale4.761,6437,82187,528Nov 17 04:08 PM